ATRC Stock Analysis: Buy, Sell, or Hold?
ATRC - AtriCure, Inc.
$48.98
1.49 (3.14%)
▲
5d:
+10.56%
30d:
+48.42%
90d:
+69.95%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When ATRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ATRC is 12.2% above its trading range ($43.64). Market expects 9.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ATRC is 12.2% above its trading range ($43.64). Market expects 9.5% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.02
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRC is currently trading at $48.98, which is considered extended relative to its 30-day fair value range of $35.02 to $43.64. From a valuation perspective, the stock is trading at a premium (Forward PE: 113.4) compared to its historical average (86.4). At these levels, the market is pricing in 9.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is approaching resistance at $49.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: ATRC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is approaching resistance at $49.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: ATRC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$35.02 -
$43.64
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
18.1%
All Signals
- BEARISH: Price significantly overextended (+12.2% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- NEUTRAL: Near Wall St target ($47.33)
- NEUTRAL: Trading at premium valuation - market expects 9.5% growth which is achievable
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$35.02 -
$43.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$41.01
Resistance Level
$49.20
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
113.43
Wall Street Target
$47.33
(-3.4%)
Revenue Growth (YoY)
12.8%
Profit Margin
1.8%
Valuation Premium vs History
+9.5% premium
PE vs Historical
113.4 vs 86.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.5%
(market-implied from PE analysis)
1-Year Target
$53.63
(+10%)
2-Year Target
$58.73
(+20%)
3-Year Target
$64.31
(+31%)
3-Yr Target (if PE normalizes)
(PE: 113→86)
PE COMPRESSION
$48.98
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 113.4, Growth: 51.9%)
$165.31
(+238%)
Base:
(SPY PE: 20.1, Growth: 51.9%)
$29.25
(-40%)
Bear:
(PE: 17.1, Growth: 51.9%)
$24.86
(-49%)
Share & Embed Analysis
Last updated: August 23, 2026 12:23 AM ET
Data refreshes hourly during market hours. Next update: 1:23 AM
Data refreshes hourly during market hours. Next update: 1:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Vinayak Doraiswamy
SELL
5000 shares
2026-03-12
Gilbert Ray Cisneros, Jr.
BUY
2026-03-03
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 41 HOLD |
